Moleculin Biotech, Inc. Share Price

NASDAQ: MBRX

Small Cap

$0.39

+0.02

(+4.14%)

Live

as on September 18, 2025 at 12:41 am IST

$₹

Moleculin Biotech, Inc. Stock Performance

as on September 18, 2025 at 12:41 am IST

Day's Low
Day's High
$0.37
Day's Price Range
$0.4
$0.39
5.13%
Downside
2.56%
Upside
52 Week's Low
52 Week's High
$0.25
52-Week Price Range
$3.65
$0.39
35.90%
Downside
835.87%
Upside

Moleculin Biotech, Inc. share price movements today

Previous Close: $0.37
Open: $0.37
Volume: 1.6M
Day's Low - High: $0.37 - $0.4
52 Week Low - High: $0.25 - $3.65

Moleculin Biotech, Inc. Historical Returns

1 Month Return: -45.54 %
3 Month Return: -44.19 %
1 Year Return: -84.12 %
3 Year Return: -98.11 %
5 Year Return: -99.49 %

Moleculin Biotech, Inc. Stock Fundamentals & Key Indicators

Check Moleculin Biotech, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.3M

EPS (TTM)

-5.28

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-25.3M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

14147500.00%

Moleculin Biotech, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Moleculin Biotech, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Moleculin Biotech, Inc.	BUY	$11.3M	-99.49%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Moleculin Biotech, Inc. Stock including INR - Dollar returns

The Moleculin Biotech, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Moleculin Biotech, Inc. investment value today

Current value as on today

₹21,265

Returns

₹78,735

(-78.74%)

Returns from Moleculin Biotech, Inc. Stock

₹83,333 (-83.33%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Moleculin Biotech, Inc. Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Moleculin Biotech, Inc.. Average target price of $6.67

Moleculin Biotech, Inc. Share Price Target

Get share price movements and forecasts by analysts on Moleculin Biotech, Inc..

What analysts predicted

94.15%UPSIDE

Target Price

$6.67

Current Price

$0.39

Analyzed by

9 Analysts

Target

$6.67

Moleculin Biotech, Inc. target price $6.67, a slight upside of 94.15% compared to current price of $0.39. According to 9 analysts rating.

Moleculin Biotech, Inc. Stock's Interest Amongst Investors

Investment in Moleculin Biotech, Inc. Shares on INDmoney has grown by 13.79% over the past 30 days, indicating increased transactional activity.

Time period: August 19, 2025 to September 18, 2025

Change:13.79% versus previous 30 day period

Search interest for Moleculin Biotech, Inc. Stock has increased by 56% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:56% versus previous 30 day period

Moleculin Biotech, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	0	-	-	0	0	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-8	-6	-5	-8	-6	-6	-7	-6	-5	-5
EBITDA	-8	-6	-5	-8	-6	-6	-7	-6	-5	-7
Interest Expense	0	-	-	0	0	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-5	-5	-10	-4	-4	-10	-1	-6	-7
Income Tax Expense	0	0	0	0	0	-	-	-	-	-
Net Income	-7	-5	-5	-10	-4	-4	-10	-1	-6	-7
Net Profit Margin	0.00%	0.00%	0.00%	-2529.31%	-1224.14%	0.00%	0.00%	-1493.65%	-10215.87%	0.00%

Moleculin Biotech, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	0	-	-	-	-	-	-	-
Gross Profit	-	0	0	0	0	0	0	0	0	0
Operating Income	0	-3	-8	-15	-17	-19	-22	-30	-29	-26
EBITDA	0	-3	-8	-14	-13	-19	-22	-30	-29	-21
Interest Expense	-	0	-	-	8	0	7	1	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	0	-3	-9	-11	-13	-17	-15	-29	-29	-21
Income Tax Expense	-1	-	1	3	0	-2	-7	-1	-	-
Net Income	0	-3	-9	-11	-13	-17	-15	-29	-29	-21
Net Profit Margin	0.00%	0.00%	-108944.44%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Moleculin Biotech, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-5	-5	-10	-4	-4	-10	-1	-6	-7
Operating Cash Flow	-5	-7	-5	-6	-5	-6	-5	-4	-5
Investing Cash Flow	0	0	0	0	0	-	-	-	-
Financing Cash Flow	0	0	4	0	0	4	0	7	5
Change in Cash	-5	-7	-1	-6	-5	-1	-5	3	0

Moleculin Biotech, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-3	-9	-11	-13	-17	-15	-29	-29	-21
Operating Cash Flow	-3	-7	-12	-17	-17	-18	-27	-24	-23
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	8	10	12	0	22	74	0	4	4
Change in Cash	4	2	0	3	4	55	-27	-19	-19

Global Institutional Holdings in Moleculin Biotech, Inc.

Funds	Holdings
Armistice Capital, LLC	4.14%
Cetera Investment Advisers	0.23%
LPL Financial Corp	0.15%
VERUS CAPITAL PARTNERS, LLC	0.14%
Vanguard Group Inc	0.1%

See all

Insights on Moleculin Biotech, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 152.1%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 214.6%
NEGATIVE IMPACT
Price Dip
In the last 1 month, MBRX stock has moved down by -45.1%

About Moleculin Biotech, Inc.

moleculin biotech, inc. is a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on discoveries made at m.d. anderson cancer center. our lead product candidate is annamycin, a phase ii clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as aml. we also have two pre-clinical small molecule portfolios, one of which is focused on the modulation of hard-to-target tumor cell signaling mechanisms and the recruitment of the patient’s own immune system. the other portfolio targets the metabolism of tumors.

Organisation	Moleculin Biotech, Inc.
Headquarters	5300 Memorial Drive, Houston, TX, United States, 77007
Industry	Health Technology
CEO	Mr. Walter V. Klemp
E-voting on shares	Click here to vote

Key Management of Moleculin Biotech, Inc.

Name	Title
Dr. John Paul Waymack M.D., Sc.D.	Senior Chief Medical Officer
Mr. Walter V. Klemp	Co-Founder, Chairman, President & CEO
Mr. Jonathan P. Foster CPA	Executive VP & CFO
Dr. Donald H. Picker Ph.D.	Chief Scientific Officer
Dr. Waldemar Priebe Ph.D.	Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board

FAQs

What is Moleculin Biotech, Inc. share price today?

Moleculin Biotech, Inc. share price today is $0.39 as on September 18, 2025 at 12:41 am IST. Moleculin Biotech, Inc. share today touched a day high of $0.4 and a low of $0.37.

What is the 52 week high and 52 week low for Moleculin Biotech, Inc. share?

Moleculin Biotech, Inc. share touched a 52 week high of $3.65 on February 13, 2025 and a 52 week low of $0.25 on June 20, 2025. Moleculin Biotech, Inc. stock price today i.e. September 18, 2025 at 12:41 am IST is trending at $0.39,which is 89.31% down from its 52 week high and 56.00% up from its 52 week low.

What is Moleculin Biotech, Inc.'s market capitalisation today?

Moleculin Biotech, Inc. market capitalisation is $0.00T as on September 18, 2025 at 12:41 am IST.

How to invest in Moleculin Biotech, Inc. Stock (MBRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Moleculin Biotech, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Moleculin Biotech, Inc. Shares that will get you 3.8462 shares as per Moleculin Biotech, Inc. share price of $0.39 per share as on September 18, 2025 at 12:41 am IST.

What is the minimum amount required to buy Moleculin Biotech, Inc. Stock (MBRX) from India?

Indian investors can start investing in Moleculin Biotech, Inc. (MBRX) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 12:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Moleculin Biotech, Inc. stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 12:42 am IST). Based on Moleculin Biotech, Inc. share’s latest price of $0.39 as on September 18, 2025 at 12:41 am IST, you will get 25.6410 shares of Moleculin Biotech, Inc.. Learn more about fractional shares .

What are the returns that Moleculin Biotech, Inc. has given to Indian investors in the last 5 years?

Moleculin Biotech, Inc. stock has given -99.49% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?